OTIF Ventures

Founding Partners George Robinson and Ross Hyett lead the firm alongside Partners James Mallinson and Christopher Hall. Mallinson, who joined in 2018, previously managed the University of Oxford’s technology spinout portfolio for 15 years as Director of Oxford Spinout Equity Management. The firm’s investment team includes Principals Tania Wilson and William Middleton, Senior Associate Alexander Chamberlain, and Associate Hector Edwards.

The firm sources primarily from the University of Oxford ecosystem. James Mallinson’s prior role managing Oxford’s spinout equity portfolio provides direct access to technology licensing and academic founder networks. George Robinson’s position as an Honorary Fellow at Keble College and his history on the Oxford University Endowment Investment Committee deepen institutional ties. OTIF Ventures also co-invests with Oxford Science Enterprises, the university’s dedicated spinout investment vehicle.

OTIF Ventures is an asset manager that operates the Oxford Technology and Innovations EIS Fund—a tax-advantaged vehicle under the UK’s Enterprise Investment Scheme. The structure allows individual UK taxpayers to invest in university spinouts with EIS tax reliefs. The firm acts as both fund manager and active board-level investor, with team members serving as board representatives for portfolio companies.

The firm invests from Seed to exit, with over 150 investments across the full lifecycle. It focuses on early-stage university spinouts but also participates in select de-risked growth rounds. The portfolio includes Seed-stage companies like Panda Surgical and later-stage ventures such as OrganOx, which achieved a $1.5 billion exit to Terumo in 2025.

George Robinson co-founded Technikos LLP, a private equity partnership that invests in biomedical engineering spinouts from Oxford’s Institute of Biomedical Engineering. OTIF Ventures maintains a business-partner relationship with Technikos, and William Middleton serves as portfolio manager for both firms. Ross Hyett is a Senior Partner at Windsor Private Office, a multi-family office, bringing additional HNW and family office investor relationships to the OTIF Ventures network.

OTIF Ventures makes direct investments in university spinout companies through its EIS fund. The firm does not publicly disclose making commitments to third-party venture funds. Its model relies on direct equity and board-level engagement with portfolio companies, sourced from the University of Oxford and other UK research institutions, rather than a fund-of-funds approach.

The firm co-invests with university-affiliated and institutional partners. Oxford Science Enterprises is a named co-investor across multiple deals in the Oxford spinout ecosystem. The firm’s EIS structure and board-representation model indicate a preference for leading or co-leading rounds where it can add governance value, rather than passive syndicate participation.